Dealing with woman’s health issues…
working to eliminate cervical cancer.
Healthcare
Biotechnology & Drugs
NASD: DIGE
Digene Corporation
Evan Jones
Chairman and Chief Executive Officer
Interview conducted by:
Diane Reynolds, Co-Publisher
Introduction & Career History:
Evan Jones -
My name is Evan Jones and I am the chairman and CEO of Digene Corporation. I began in this field nearly two decades ago. My family was involved with the diagnostic
business that created one of the first companies. In
1990, we had a vision to create a company that was developing gene tests for treatable
diseases. We were one of the first companies
to enter this market and through the 1990’s we developed our business and market
position. We are now one of the leaders in
the field with Digene and we created a unique technology called Hybrid Capture, which
allows gene testing, and virtually any lab setting and our lead product is for the cause
of cervical cancer. We have the only FDA
cleared product for the cause of cervical cancer and the sales now are growing rapidly. As we discussed earlier the total revenues for our
business grew 37% in the last quarter, to $7.2 million dollars.
Ceocfointerviews: Do you deal
strictly with Women’s Health Issues?
Evan Jones: That is the primary
focus of the company. We are working to
become the world leader in gene testing for women’s cancers and infectious disease.
Ceocfointerviews: Are other areas that could possibly use your
product?
To receive a FREE copy of this interview E-mail: info@ceocfointerviews.com
or call: 570-839-0236. Please remember to include your full name, return e-mail address
and the interview you are requesting. Your only cost
will be a $2.00 handing fee, which will billed at a later date. |
